Suwinski R, Maciejewski B, Withers H R
Center of Oncology, M. Sklodowska-Curie Memorial Institute, Gliwice, Poland.
Neoplasma. 1998;45(2):107-12.
The aim of this study is to assign dose-response relationship for subclinical neck metastases of squamous cell head and neck cancer based on extensive survey of 24 data sets collected from the literature. Neck relapse rates (NRR) without and after elective (ENI) or preoperative irradiation were estimated for each site and stage of primary tumor and the reduction in neck relapse rate was calculated. An average NRR without ENI was 22% (12-35%) and only 2.5% (0-10%) after the ENI with total dose of 46-50 Gy which gives high reduction rate in the risk of neck recurrences being on the average 89% and 42% (0-46%) after preoperative irradiation using 22-30 Gy. Dose response curve for elective and preoperative irradiation have shown that 50 Gy in 2 Gy fraction reduces the incidence of neck relapses in the N0 patients by more than 90% and only by less than 50% after total doses lower than 30 Gy. No correlation between the risk of neck metastases without ENI and the reduction in neck relapses after ENI was found.
本研究的目的是基于对从文献中收集的24个数据集的广泛调查,确定头颈部鳞状细胞癌亚临床颈部转移的剂量反应关系。针对原发肿瘤的每个部位和阶段,估计了未进行选择性(ENI)或术前放疗以及进行放疗后的颈部复发率(NRR),并计算了颈部复发率的降低情况。未进行ENI时的平均NRR为22%(12%-35%),而在ENI且总剂量为46-50 Gy后,平均NRR仅为2.5%(0%-10%),这表明颈部复发风险的降低率平均为89%;在使用22-30 Gy进行术前放疗后,颈部复发风险的降低率为42%(0%-46%)。选择性放疗和术前放疗的剂量反应曲线表明,以2 Gy分割给予50 Gy可使N0患者的颈部复发率降低90%以上,而在总剂量低于30 Gy后,颈部复发率仅降低不到50%。未发现未进行ENI时的颈部转移风险与ENI后颈部复发率降低之间存在相关性。